Methods of treating RBP4 related diseases with triazolopyridines
US11007186B2 · kind B2 · utility
5Cited by
11References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 11, 2019 |
| Grant date | May 18, 2021 |
| Priority date | — |
| Expiry date | Feb 11, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P3/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are heterocyclic derivative compounds and pharmaceutical compositions comprising said compounds that are useful for the treatment of retinal binding protein (RBP4) related diseases, such as obesity and the like.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.